Table 1 Frequency of drug prescribing
Drug | Proportion of all patients prescribed drug at some point during the study period (%) | Median daily dose (for drugs taken by ≥5% of patients) | Minimum effective daily dose 32 , where established |
|---|---|---|---|
First-generation antipsychotics | |||
Chlorpromazine | 12.0 | 150 mg | 200 mg33a |
Flupentixol | 15.7 | 6 mg | |
Fluphenazine | 4.0 | – | – |
Haloperidol | 20.1 | 10 mg | 4 mg32 |
Levomepromazine | 0.1 | – | – |
Pericyazine | 0.1 | – | – |
Perphenazine | 0.1 | – | – |
Pimozide | 0.7 | – | – |
Pipotiazine | 5.1 | 7.1 mg | 21 mg36a |
Prochlorperazine | 0.5 | – | – |
Promazine | 0.4 | – | – |
Sulpiride | 5.7 | 400 mg | 400 mg33a |
Trifluoperazine | 7.5 | 10 mg | 10 mg33a |
Zuclopenthixol | 8.8 | 37.9 mg | 14 mg37a |
Second-generation antipsychotics | |||
Amisulpride | 15.5 | 400 mg | 400 mg33a |
Aripiprazole | 16.8 | 15 mg | 10 mg32 |
Asenapine | 0.1 | – | – |
Clozapine | 27.1 | 250 mg b | 300 mg32 |
Olanzapine | 39.3 | 12.5 mg | 7.5 mg32 |
Paliperidone | 2.4 | – | – |
Quetiapine | 17.6 | 300 mg | 150 mg32 |
Risperidone | 31.9 | 3.6 mg | 2 mg32 |
Antidepressants used by ≥5% of patients | |||
Citalopram | 15.2 | 20 mg | 20 mg33 |
Fluoxetine | 10.8 | 20 mg | 20 mg33 |
Mirtazapine | 10.0 | 30 mg | 30 mg33 |
Sertraline | 7.3 | 100 mg | 50 mg33 |
Venlafaxine | 5.9 | 150 mg | 75 mg33 |